15.363 Strategic Decision Making in the Biomedical Business
Spring 2014
Instructors: jfleming@oxbio.com, Andrey Zarur
TAs: Andrew Douglas Bower, Sarah Elizabeth Cooper-Davis
Lecture: T 5:30-8:30 PM (E51-315)
Information:
Announcements
Class Site
At the end of lecture yesterday, a class site was mentioned for all of you to keep in touch. The talk was of something on Facebook, but I can actually direct you to a LinkedIn group:https://www.linkedin.com/groups?gid=3858222
Please join to stay in touch! We had a great semester and hope you did, too.
Regards,
Sarah & Andrew
Announced on 14 May 2014 9:51 p.m. by Sarah Elizabeth Cooper-Davis
HW4 Posted & Other Reminders
Class,
Homework 4 has been posted to Stellar. You have until the last night of class (Tuesday, May 13) to hand in this assignment. If you need your final grade before May 13 please email your completed assignment to Professor Zarur before the date your grade is needed.
All students should be reminded we will not class tomorrow. Graded Homework 3 will be returned the next time we meet on April 29.
Announced on 21 April 2014 10:40 p.m. by Andrew Douglas Bower
HW3 Posted
Homework 3 has now been posted. Slides from the April 1 lecture are also available on Stellar. Enjoy!
Announced on 03 April 2014 10:47 a.m. by Andrew Douglas Bower
Mid-Term Clarification
There seems to be a little bit of confusion around calculating manufacturing costs for both Zarco and Fleming & Sons. The case says, " Manufacturing costs for Z-1001 at scale are estimated to be around $500 per dose per patient." The $500 figure is the total annual cost of manufacturing even though Z-1001 is administered to patients monthly.
Please email Sarah and me if you have any questions.
Announced on 08 March 2014 4:00 p.m. by Andrew Douglas Bower
Mid-term Project - PLEASE DELETE THE EMAIL YOU JUST GOT!
I just send out the team assignments to groups. I replied to the original team preference. DO NOT OPEN THAT EMAIL - PLEASE DELETE IMMEDIATELY! I will be sending out the actually assignment momentarily.Announced on 27 February 2014 1:40 p.m. by Sarah Elizabeth Cooper-Davis
